Trade Summary

6 days ago, Mancini Marianna, serving as Chief Operating Officer at Viking Therapeutics, Inc. (VKTX), sold 18,217 shares at $33.47 per share, for a total transaction value of $609,635.55. Following this transaction, Mancini Marianna now holds 422,760 shares of VKTX.

This sale represents a 4.13% decrease in Mancini Marianna's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, July 29, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 30, 2026 (accepted Jul 29, 8:06 PM ET), 1 day after the trade was made.

Viking Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.